Ongoing
Closed
Study of the mechanisms of CC Chemokine Receptor type 2 (CCR2) overexpression in myelofibrosis: their involvement in CCL2-mediated disease progression and preclinical validation of CCR2 blockade as a new therapeutic strategy
Sun Jan 1, 2023